PhaseRx, Inc.

Get the PZRX Research Report and Also Receive Our Top Trades for 2017! The company announced that its lead candidate, PRX-OTC, which is being developed for the treatment of ornithine transcarbamylase deficiency (OTCD), has received orphan drug designation by the U.S....

Recro Pharma, Inc.

Get the REPH Research Report and Also Receive Our Top Trades for 2017! The company announced positive results from its second of two Phase III clinical trials evaluating intravenous (IV) meloxicam for the treatment of acute postoperative pain. In this trial, IV...

Fang Holdings Limited

Get the SFUN Research Report and Also Receive Our Top Trades for 2017! Fang reported total revenues of $250.1 million in the third quarter of 2016, a 1% increase from $248.5 million in the corresponding period of 2015, primarily driven by the growth of e-commerce...